Meliora Therapeutics Private Limited

Meliora Therapeutics Private Limited - chemicals and materials in Hyderabad, Telangana, India. Directors, charges & compliance details.
CIN U24290TG2021PTC156140 Incorporated 21 October 2021 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company chemicals and materials
Revenue · FY 2025
₹43,986
▼ 80% YoY
Net loss · FY 2025
₹7.63 Lakh
Latest filing
EBITDA · FY 2025
-₹5.32 Lakh
Latest filing
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹2 Cr
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Meliora Therapeutics Private Limited

Data last updated:

Meliora Therapeutics Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 21 October 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24290TG2021PTC156140.

The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It is led by directors Ravindra Babu Gogineni and Saichandra Gogineni.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H No. 5 – 315 S R C Naik Nagar Ida Jeedimetla Qutubullapur, Hyderabad, Telangana, India – 500055.

As per the financials filed for FY 2025, the company reported a revenue of ₹43,986, a decline of 80% compared to the previous year. For the same year it recorded a net loss of ₹7.63 Lakh and EBITDA of -₹5.32 Lakh.

Company details

CIN U24290TG2021PTC156140
Registration Number 156140
Incorporation Date 21 October 2021
ROC Hyderabad
Listing Status Unlisted
Company Status Active

Contact details

Meliora Therapeutics Private Limited's registered office is in Hyderabad, Telangana.

  • Registered Address
    H No. 5 – 315 S R C Naik Nagar Ida Jeedimetla Qutubullapur, Hyderabad, Telangana, India – 500055
  • Industry
    Chemicals and Materials, Industrial Chemicals
Comprehensive company report
Meliora Therapeutics Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Meliora Therapeutics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Meliora Therapeutics Private Limited, buy the company report.

Financials of Meliora Therapeutics Private Limited

FY 2025 filings available

Meliora Therapeutics Private Limited reported revenue of ₹43,986 (down 80% YoY) for FY 2025.

Revenue · FY 2025
₹43,986 ▼ 80%
Net loss · FY 2025
₹7.63 Lakh
EBITDA · FY 2025
-₹5.32 Lakh

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 80%
EBITDA CAGR growth
1 year
▼ 16%
3 years · compounded
▼ 123%

Revenue fell 80% in the latest year. EBITDA fell 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹5.32 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹7.63 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Meliora Therapeutics Private Limited, buy the company report.

Board of directors of Meliora Therapeutics Private Limited

Meliora Therapeutics has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Ravindra Babu GogineniDirector21 Oct 20215 Years 0 MonthsCurrent
Saichandra GogineniDirector21 Oct 20215 Years 0 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Meliora Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Meliora Therapeutics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Meliora Therapeutics Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Ravindra Babu Gogineni was appointed as Director on 21 Oct 2021.

AGM
Meliora Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Meliora Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Ravindra Babu Gogineni was appointed as Director.
Appointed
Saichandra Gogineni was appointed as Director.
Incorporation
21 Oct 2021
Meliora Therapeutics Private Limited was registered on 21 Oct 2021 with Roc Hyderabad & aged 5 years 28 days as per MCA records.

Frequently asked questions

Meliora Therapeutics is an active private limited company based in Hyderabad, Telangana, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 21 October 2021 (5+ years old) and is registered under CIN U24290TG2021PTC156140.

Meliora Therapeutics has 2 current directors:

The latest financial statements of Meliora Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.

The CIN (Corporate Identification Number) of Meliora Therapeutics is U24290TG2021PTC156140. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Meliora Therapeutics was incorporated on 21 October 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.

Ravindra Babu Gogineni was appointed as Director on 21 Oct 2021. Saichandra Gogineni was appointed as Director on 21 Oct 2021.

The registered office of Meliora Therapeutics is at H No. 5 – 315 S R C Naik Nagar Ida Jeedimetla Qutubullapur, Hyderabad, Telangana, India – 500055.

Meliora Therapeutics operates in the chemicals and materials industry, in the industrial chemicals segment.

Meliora Therapeutics can be reached at its registered office: H No. 5 – 315 S R C Naik Nagar Ida Jeedimetla Qutubullapur, Hyderabad, Telangana, India – 500055.

Meliora Therapeutics is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.